These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2039374)

  • 21. Kinetics of deoxyglucose (DG) and fluorodeoxyglucose (FDG) metabolism in rat and ferret brain.
    Miller AL; Hawkins RA
    J Cereb Blood Flow Metab; 1990 Jan; 10(1):147-8. PubMed ID: 2298832
    [No Abstract]   [Full Text] [Related]  

  • 22. Perfusion and metabolism in predicting the survival of patients with cerebral gliomas.
    Mineura K; Sasajima T; Kowada M; Ogawa T; Hatazawa J; Shishido F; Uemura K
    Cancer; 1994 May; 73(9):2386-94. PubMed ID: 8168042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo disturbance of the oxidative metabolism of glucose in human cerebral gliomas.
    Rhodes CG; Wise RJ; Gibbs JM; Frackowiak RS; Hatazawa J; Palmer AJ; Thomas DG; Jones T
    Ann Neurol; 1983 Dec; 14(6):614-26. PubMed ID: 6606389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Glioma and free radical].
    Yoshii Y
    No Shinkei Geka; 1998 Jul; 26(7):571-81. PubMed ID: 9666490
    [No Abstract]   [Full Text] [Related]  

  • 25. Does deoxyglucose uptake in the brain reflect energy metabolism?
    Gjedde A
    Biochem Pharmacol; 1987 Jun; 36(12):1853-61. PubMed ID: 3297067
    [No Abstract]   [Full Text] [Related]  

  • 26. Fluorodeoxyglucose (FDG) and tumour metabolism.
    Van Wyngaarden KE; Pauwels EK
    Nucl Med Commun; 1995 Dec; 16(12):987-9. PubMed ID: 8719978
    [No Abstract]   [Full Text] [Related]  

  • 27. [Metabolic studies of gliomas with positron emission tomography and phosphorus 31 MR spectroscopy in diagnosis and treatment planning].
    Jeske J; Herholz K; Heindel W; Heiss WD
    Onkologie; 1989 Aug; 12 Suppl 1():42-5. PubMed ID: 2685695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome.
    Valk PE; Budinger TF; Levin VA; Silver P; Gutin PH; Doyle WK
    J Neurosurg; 1988 Dec; 69(6):830-8. PubMed ID: 2848111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relation between tissue nature and (18F) fluorodeoxyglucose kinetics evaluated by dynamic positron emission tomography in human brain tumors.
    Yamaguchi T; Sasaki H; Ogawa T; Mineura K; Uemura K; Kanno I; Shishido F; Murakami M; Inugami A; Higano S
    Acta Radiol Suppl; 1986; 369():415-8. PubMed ID: 2980513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic imaging of human brain tumors.
    Wilson CB
    Semin Neurol; 1989 Dec; 9(4):388-93. PubMed ID: 2534935
    [No Abstract]   [Full Text] [Related]  

  • 31. Metabolism of [14C]fluorodeoxyglucose by rat brain in vivo.
    Miller AL; Kiney C
    Life Sci; 1981 May; 28(18):2071-6. PubMed ID: 7242268
    [No Abstract]   [Full Text] [Related]  

  • 32. In vivo imaging of glucose consumption and lactate concentration in human gliomas.
    Herholz K; Heindel W; Luyten PR; denHollander JA; Pietrzyk U; Voges J; Kugel H; Friedmann G; Heiss WD
    Ann Neurol; 1992 Mar; 31(3):319-27. PubMed ID: 1637139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Positron emission tomographic evaluations on hemodynamics and glucose metabolism of brain tumors and perifocal edematous tissues].
    Mizukawa N; Hino A; Imahori Y; Tenjin H; Yano I; Yoshino E; Hirakawa K; Yamashita M; Oki F; Nakahashi H
    No To Shinkei; 1989 Mar; 41(3):251-8. PubMed ID: 2787998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Finding drugs against CD133+ glioma subpopulations.
    Nakano I; Chiocca EA
    J Neurosurg; 2011 Mar; 114(3):648; discussion 648-50. PubMed ID: 21054138
    [No Abstract]   [Full Text] [Related]  

  • 35. Glucose consumption in recurrent gliomas.
    Ishikawa M; Kikuchi H; Miyatake S; Oda Y; Yonekura Y; Nishizawa S
    Neurosurgery; 1993 Jul; 33(1):28-33. PubMed ID: 8355844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of oxidative phosphorylation confers resistance against bevacizumab in experimental glioma.
    Eriksson JA; Wanka C; Burger MC; Urban H; Hartel I; von Renesse J; Harter PN; Mittelbronn M; Steinbach JP; Rieger J
    J Neurochem; 2018 Feb; 144(4):421-430. PubMed ID: 29178334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Basic studies on chemotherapy of brain tumors by means of liposomes: affinity of sulfatide-inserted liposomes to human glioma cells].
    Kito A; Yoshida J; Kageyama N; Inoue I; Abe H; Arichi S; Kojima N; Yagi K
    No To Shinkei; 1987 Aug; 39(8):783-8. PubMed ID: 3426863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early changes in tumor metabolism after treatment: the effects of stereotactic radiotherapy.
    Rozental JM; Levine RL; Mehta MP; Kinsella TJ; Levin AB; Algan O; Mendoza M; Hanson JM; Schrader DA; Nickles RJ
    Int J Radiat Oncol Biol Phys; 1991 May; 20(5):1053-60. PubMed ID: 2022505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amino Acid Metabolism Abnormity and Microenvironment Variation Mediated Targeting and Controlled Glioma Chemotherapy.
    An S; Lu X; Zhao W; Sun T; Zhang Y; Lu Y; Jiang C
    Small; 2016 Oct; 12(40):5633-5645. PubMed ID: 27571928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential biochemical therapy of glioma cancer.
    Yin LT; Fu YJ; Xu QL; Yang J; Liu ZL; Liang AH; Fan XJ; Xu CG
    Biochem Biophys Res Commun; 2007 Oct; 362(2):225-9. PubMed ID: 17707767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.